Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Bruno

Showing results (251-260 of 302) with videos related to

Pageof 31
Sort By:
Journal of Clinical Medicine|March 11, 2023
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA ParticipantsGeorgia Stimpson, Danielle Ramsey, Amy Wolfe, et al.
Plos One|June 25, 2021
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow upGiorgia Coratti, Marika Pane, Claudia Brogna, et al.
European Journal of Neurology|April 24, 2024
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international studyGiorgia Coratti, Francesca Bovis, Maria Carmela Pera, et al.
Neuromuscular Disorders : NMD|September 19, 2024
Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb ModuleGiorgia Coratti, Matthew Civitello, Annemarie Rohwer, et al.
European Journal of Neurology|June 27, 2025
Longitudinal Assessment of 4-Year HFMSE Changes in SMA II and III Patients Treated With NusinersenGiorgia Coratti, Francesca Bovis, Marika Pane, et al.
Plos One|January 18, 2013
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophyElena Stacy Mazzone, Marika Pane, Maria Pia Sormani, et al.
Journal of Neuromuscular Diseases|March 1, 2024
Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3Amy Wolfe, Georgia Stimpson, Danielle Ramsey, et al.
Muscle & Nerve|July 30, 2021
Different trajectories in upper limb and gross motor function in spinal muscular atrophyGiorgia Coratti, Maria Carmela Pera, Jacqueline Montes, et al.
Neuromuscular Disorders : NMD|January 4, 2022
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changesGiorgia Coratti, Maria Carmela Pera, Jacqueline Montes, et al.
Journal of Neurology|May 11, 2015
Centronuclear myopathies: genotype-phenotype correlation and frequency of defined genetic forms in an Italian cohortFabiana Fattori, Lorenzo Maggi, Claudio Bruno, et al.
Pageof 31

Showing results (251-260 of 302) with videos related to

Sort By:
Pageof 31
Journal of Clinical Medicine|March 11, 2023
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA ParticipantsGeorgia Stimpson, Danielle Ramsey, Amy Wolfe, et al.
Plos One|June 25, 2021
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow upGiorgia Coratti, Marika Pane, Claudia Brogna, et al.
European Journal of Neurology|April 24, 2024
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international studyGiorgia Coratti, Francesca Bovis, Maria Carmela Pera, et al.
Neuromuscular Disorders : NMD|September 19, 2024
Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb ModuleGiorgia Coratti, Matthew Civitello, Annemarie Rohwer, et al.
European Journal of Neurology|June 27, 2025
Longitudinal Assessment of 4-Year HFMSE Changes in SMA II and III Patients Treated With NusinersenGiorgia Coratti, Francesca Bovis, Marika Pane, et al.
Plos One|January 18, 2013
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophyElena Stacy Mazzone, Marika Pane, Maria Pia Sormani, et al.
Journal of Neuromuscular Diseases|March 1, 2024
Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3Amy Wolfe, Georgia Stimpson, Danielle Ramsey, et al.
Muscle & Nerve|July 30, 2021
Different trajectories in upper limb and gross motor function in spinal muscular atrophyGiorgia Coratti, Maria Carmela Pera, Jacqueline Montes, et al.
Neuromuscular Disorders : NMD|January 4, 2022
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changesGiorgia Coratti, Maria Carmela Pera, Jacqueline Montes, et al.
Journal of Neurology|May 11, 2015
Centronuclear myopathies: genotype-phenotype correlation and frequency of defined genetic forms in an Italian cohortFabiana Fattori, Lorenzo Maggi, Claudio Bruno, et al.
Pageof 31